SHROOQ PHARMACEUTICALS
Pharmaceutical company · 274 brands · 216 molecules
Ranked #1 of 178 companies in Antiinflammatory And Antirheumatic Products
Company overview
SHROOQ PHARMACEUTICALS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 274 product registrations across 216 distinct molecules. It is the 38th largest registrant in Pakistan by product count, and ranks 1st of 178 in Antiinflammatory And Antirheumatic Products. Its portfolio is concentrated in Antiinflammatory And Antirheumatic Products and Other Beta-Lactam, Cephalosporins & Penems. DRAP has issued 1 alert involving its products.
Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.
Products by SHROOQ
30 products matched in our catalogue — each with its observed price and DRAP approved ceiling.
Price ceiling age
DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.
Top molecules by brand count
Therapeutic classes
Conditions treated
Price band (DRAP official ceilings)
Regulatory record
1 alert in the DRAP feed we track.
Competitive set
Companies whose registered portfolio overlaps most with this one.
Portfolio whitespace
Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.
Get the full profile for SHROOQ
This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.
Request this brief See what’s included